BMO Hosts First Obesity Summit on Future of Obesity Care Market

News Release
  • checkmark icon

    ​Healthcare industry experts and leaders will convene at inaugural BMO Obesity Summit to examine outlook and trends in obesity treatment


NEW YORK, March 13, 2024 /CNW/ - BMO will host its first Obesity Summit on March 20, 2024, in New York City. The conference will target buy-side investors who want to hear from leading biotech and pharmaceutical companies developing medical weight-management therapeutics and stakeholders across the continuum of care and delivery. Topics straight from the headlines will be discussed via panels and presentations, including:


    • checkmark icon

      A panel on the emerging therapeutic landscape

    • checkmark icon

      The Patient's Voice: a conversation with patients on GLP-1+ therapy

    • checkmark icon

      Obesity 101 with Intellihealth, featuring Dr Katherine Saunders

    • checkmark icon

      Care delivery featuring Beth Israel Lahey Health, Weight Watchers, and Intellihealth

    • checkmark icon

      A key opinion leader's insights on metabolic research, featuring Weill Cornell Medical College's Dr Louis J. Aronne

    • checkmark icon

      A payors panel addressing coverage and access, featuring Prime Therapeutics


"Important conversations need to happen around the development and delivery of obesity care," said Evan Seigerman, Senior Biotechnology & Pharmaceuticals Analyst, BMO. "This summit is about having those discussions and sharing ideas and solutions from thought leaders and experts who can move the dial to meet challenges to deliver care for patients with obesity and metabolic disease."


BMO analysts, including Evan Seigerman, will host discussions with leading life sciences companies, including:


    • checkmark icon

      Altimmune

    • checkmark icon

      Amgen

    • checkmark icon

      Capital Rx

    • checkmark icon

      Corbus Pharmaceuticals

    • checkmark icon

      Eli Lilly & Co.

    • checkmark icon

      Novo Nordisk

    • checkmark icon

      Intellihealth

    • checkmark icon

      Prime Therapeutics

    • checkmark icon

      Scholar Rock

    • checkmark icon

      Structure Therapeutics

    • checkmark icon

      Terns Pharmaceuticals

    • checkmark icon

      Weight Watchers


For more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There are restrictions for media on access to presentations and certain speakers.

About BMO Financial Group


BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.3 trillion as of January 31, 2024. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society.


SOURCE BMO Financial Group

​

For further information: Media contact: Kelly Hechler, Toronto, kelly.hechler@bmo.com, (416) 867-3996